The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Androgen Treatment of Abdominally Obese Men
Open accessAbstract
Middle‐aged men with abdominal obesity were treated in a double‐blind study with moderate doses of transdermal preparations of testosterone (T), dihydrotestosterone (DHT), or placebo. This resulted in moderately elevated T concentrations and marked decreases in follicle stimulating and luteinizing hormones in the group treated with T, while the DHT group showed elevated DHT, markedly lower T values, and less diminution of gonadotropin concentrations. In the group treated with T visceral fat mass decreased (measured by computerized tomography) without significant changes in other depot fat regions. Lean body mass did not change. In the group treated with T, glucose disposal rate, measured with the euglycemic hyperinsulinemic clamp method, was markedly augmented. Plasma triglycerides, cholesterol, and fasting blood glucose concentrations as well as diastolic blood pressure decreased. There were no such changes in the DHT or placebo treatment groups. The men treated with T reported increased well‐being and energy. In none of the groups did prostate volume, specific prostate antigen concentration, genitourinary history, or urinary flow measurement change. It is suggested that supplementation of abdominal obese men with moderate doses of T might have several beneficial effects. (OBESITY RESEARCH 1993;1:245–251)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in serum triglycerides follows a similar pattern: after 4 weeks (38), after 3 months (35), and with further decrease over 9 months (41) or 12 months (43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [41]
In the citing paper
“In some studies a decline in diastolic blood pressure has been observed, after 3–9 months (22, 35, 41, 44) and in some studies in systolic blood pressure also (35, 44).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Kvist, H., Chowdhury, B., Grangård, U., Tylén, U., & Sjöström, L. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/48.6.1351 · Cited by 794
Self-citationSeidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Self-citationThe effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Self-citationVague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Percutaneous Absorption of Steroids*
Scheuplein, R. J., Blank, I. H., Brauner, G., & Macfarlane, D. J. (1969) · Journal of Investigative Dermatology · doi:10.1038/jid.1969.9 · Cited by 392
Testosterone: A Major Determinant of Extragenital Sexual Dimorphism
Bardin, C. W., & Catterall, J. F. (1981) · Science · doi:10.1126/science.7010603 · Cited by 381
Estimation of Total Body Fat from Potassium-40 Content
Forbes, G. B., Gallup, J., & Hursh, J. B. (1961) · Science · doi:10.1126/science.133.3446.101 · Cited by 341
Abdominal obesity and the development of noninsulin‐dependent diabetes mellitus
Björntorp, P. A. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040607 · Cited by 292
Self-citationEffect of testosterone on abdominal adipose tissue in men.
Rebuffé-Scrive, M., Mårin, P., & Björntorp, P. A. (1991) · PubMed · Cited by 223
Self-citation
Research works printed but not linked: 2
- Arvidsson B., 1972, Clinical applications of a high‐sensitivity whole‐body counter, Digest of the Third International Conference on Medical Engineering. Gothenburg, 41, 2
- WHO, 1988, Measuring obesity; classification and description of anthropometric data. Report on a WHO consultation on the epidemiology of obesity. EURMFA target 16. Regional office in Europe, 1
Cited by
Sorted by citations
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003
Gender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 596
Stahlhut, R. W., van Wijngaarden, E., Dye, T. D., Cook, S., & Swan, S. H. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9882 · Cited by 646
Xu, L., Freeman, G., Cowling, B. J., & Schooling, C. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-108 · Cited by 569
Pitteloud, N., Hardin, M., Dwyer, A. A., Valassi, E., Yialamas, M., Elahi, D., & Hayes, F. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2190 · Cited by 525
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Andropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men
Pitteloud, N., Mootha, V. K., Dwyer, A. A., Hardin, M., Lee, H., Eriksson, K.-F., Tripathy, D., Yialamas, M., Groop, L., Elahi, D., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1636 · Cited by 472
Obesity and androgens: facts and perspectives
Pasquali, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.054 · Cited by 469
Testosterone-mediated immune functions and male life histories
Muehlenbein, M. P., & Bribiescas, R. G. (2005) · American Journal of Human Biology · doi:10.1002/ajhb.20419 · Cited by 449
Medicinal strategies in the treatment of obesity
Bray, G. A., & Tartaglia, L. A. (2000) · Nature · doi:10.1038/35007544 · Cited by 432
Sex differences in obesity and the regulation of energy homeostasis
Lovejoy, J. C., Sainsbury, A., & the Stock Conference 2008 Working Group (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00529.x · Cited by 422
Boyanov, M. A., Boneva, Z., & Christov, V. G. (2003) · The Aging Male · doi:10.1080/tam.6.1.1.7 · Cited by 381
The benefits and risks of testosterone replacement therapy: a review
Morley, J. E. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3025 · Cited by 381
Wang, C., Jackson, G., Jones, T. H., Matsumoto, A. M., Nehra, A., Perelman, M. A., Swerdloff, R. S., Traish, A., Zitzmann, M., & Cunningham, G. (2011) · Diabetes Care · doi:10.2337/dc10-2339 · Cited by 366
Testosterone deficiency, insulin resistance and the metabolic syndrome
Zitzmann, M. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.212 · Cited by 359
Wittert, G., Chapman, I. M., Haren, M. T., Mackintosh, S. F., Coates, P. S., & Morley, J. E. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.7.m618 · Cited by 342
Johannsson, G., Mårin, P., Lönn, L., Ottosson, M., Stenlöf, K., Björntorp, P. A., Sjöström, L., & Bengtsson, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3809 · Cited by 336
Self-citationCurrent and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 327
Michalakis, K., Mintziori, G., Kaprara, A., Tarlatzis, B. C., & Goulis, D. G. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.012 · Cited by 321
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
Self-citationSimon, D. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.682 · Cited by 220
Lowered testosterone in male obesity: Mechanisms, morbidity and management
Grossmann, M., Tang Fui, M., & Dupuis, P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122365 · Cited by 293
Allan, C. A., Strauss, B. J. G., Burger, H. G., Forbes, E. A., & McLachlan, R. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1291 · Cited by 298
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Sandhu, S., Green, K., Makdissi, A., HEJNA, J. M., Chaudhuri, A., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1518 · Cited by 285
The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
Traish, A. M., Guay, A. T., Feeley, R. J., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.005215 · Cited by 284
Testosterone supplementation therapy for older men: potential benefits and risks
Gruenewald, D. A., & Matsumoto, A. M. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51018.x · Cited by 279
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Traish, A. M., Saad, F., & Guay, A. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005751 · Cited by 266
Neuroendocrine abnormalities in visceral obesity
Björntorp, P. A., & Rosmond, R. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801285 · Cited by 262
Self-citationSex and gender differences in control of blood pressure
Maranon, R. O., & Reckelhoff, J. F. (2013) · Clinical Science · doi:10.1042/cs20130140 · Cited by 267
Boese, A. C., Kim, S. C., Yin, K., Lee, J., & Hamblin, M. H. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00217.2016 · Cited by 241
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1067 · Cited by 260
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Traish, A. M., Saad, F., Feeley, R. J., & Guay, A. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007245 · Cited by 237
Obesity and Polycystic Ovary Syndrome
Vrbíková, J., & Hainer, V. (2009) · Obesity Facts · doi:10.1159/000194971 · Cited by 244
McCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0684 · Cited by 235
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232
Androgen Replacement Therapy in the Aging Male--A Critical Evaluation
Vermeulen, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7630 · Cited by 226
Singh, A. B., Hsia, S. H., Alaupovic, P., Sinha‐Hikim, I., Woodhouse, L. J., Buchanan, T. A., Shen, R., Bross, R., Berman, N., & Bhasin, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8172 · Cited by 225
Yialamas, M. A., Dwyer, A. A., Hanley, E., Lee, H., Pitteloud, N., & Hayes, F. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0454 · Cited by 220
Corona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0262 · Cited by 217
Lovejoy, J. C., Bray, G. A., Bourgeois, M., Macchiavelli, R. E., Rood, J. C., Greeson, C., & Partington, C. (1996) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.81.6.8964851 · Cited by 235
Testosterone Therapy and Cardiovascular Risk: Advances and Controversies
Morgentaler, A., Miner, M. M., Caliber, M., Guay, A. T., Khera, M., & Traish, A. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.011 · Cited by 213
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
Hypothalamic Origin of the Metabolic Syndrome X
Björntorp, P. A., & Rosmond, R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07803.x · Cited by 196
Self-citationTestosterone deficiency: a risk factor for cardiovascular disease?
Jones, T. H. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.03.002 · Cited by 195
Morales, Á., Johnston, B., Heaton, J. P. W., & Lundie, M. J. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65062-6 · Cited by 191
Sex Steroid Hormones, Upper Body Obesity, and Insulin Resistance
Abate, N., Haffner, S. M., Garg, A., Peshock, R. M., & Grundy, S. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020567 · Cited by 187
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
Tchernof, A., & Labrie, F. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510001 · Cited by 184
Declining gonadal function in elderly men
Kaufman, J. M., & Vermeulen, A. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80302-3 · Cited by 181
Testosterone and the Aging Male
Tenover, J. L. (1997) · Journal of Andrology · doi:10.1002/j.1939-4640.1997.tb01887.x · Cited by 178
Reduced testosterone and adrenal C19 steroid levels in obese men
Tchernof, A., Després, J.-P., Bélanger, A., Dupont, A., Prud'homme, D., Moorjani, S., Lupien, P. J., & Labrie, F. (1995) · Metabolism · doi:10.1016/0026-0495(95)90060-8 · Cited by 175
Sex differences in type 2 diabetes: focus on disease course and outcomes
Arnetz, L., Rajamand Ekberg, N., & Alvarsson, M. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s51301 · Cited by 175
Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men
Woodhouse, L. J., Gupta, N., Bhasin, M., Singh, A. B., Ross, R., Phillips, J., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031492 · Cited by 173
Hormonal control of regional fat distribution
Björntorp, P. A. (1997) · Human Reproduction · doi:10.1093/humrep/12.suppl_1.21 · Cited by 170
Self-citationAllan, C. A., & McLachlan, R. I. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283398ee2 · Cited by 168
Dean, J. D., McMahon, C. G., Guay, A. T., Morgentaler, A., Althof, S. E., Becher, E. F., Bivalacqua, T. J., Burnett, A. L. “., Buvat, J., Meliegy, A. E., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12952 · Cited by 159
Hypogonadotropic Hypogonadism in Men With Diabesity
Dhindsa, S., Ghanim, H., Batra, M., & Dandona, P. (2018) · Diabetes Care · doi:10.2337/dc17-2510 · Cited by 162
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 153
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424573 · Cited by 148
Surampudi, P. N., Wang, C., & Swerdloff, R. S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/625434 · Cited by 154
Hoyos, C. M., Yee, B. J., Phillips, C. L., Machan, E. A., Grunstein, R. R., & Liu, P. Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0525 · Cited by 145
Liu, P. Y., Swerdloff, R. S., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0807 · Cited by 143
Zhao, J., Zhu, S., Sun, L., Meng, F., Zhao, L., Zhao, Y., Tian, H., Li, P., & Niu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107516 · Cited by 141
MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone
Russell, N., & Grossmann, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-1000 · Cited by 145
Hypogonadism and androgen replacement therapy in elderly men
Basaria, S. S., & Dobs, A. S. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00663-5 · Cited by 136
Simon, D., Charles, M.-A., Lahlou, N., Nahoul, K., Oppert, J.-M., Gouault-Heilmann, M., Lemort, N., Thibult, N., Joubert, E., Balkau, B., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2149 · Cited by 136
Androgen Administration to Aging Men
Tenover, J. L. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30073-2 · Cited by 136
Gannagé‐Yared, M., Khalifé, S., Semaan, M., Fares, F., Jambart, S., & Halaby, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02175 · Cited by 134
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
Alemany, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911952 · Cited by 150
Merlotti, C., Ceriani, V., Morabito, A., & Pontiroli, A. E. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.31 · Cited by 136
Bhasin, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-1 · Cited by 127
Testosterone and Regional Fat Distribution
Mårin, P. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00233.x · Cited by 129
Self-citationAge‐related changes in testosterone and the role of replacement therapy in older men
Allan, C. A., & McLachlan, R. I. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02002.x · Cited by 128
Borst, S. E., Shuster, J. J., Zou, B., Ye, F., Jia, H., Wokhlu, A., & Yarrow, J. F. (2014) · BMC Medicine · doi:10.1186/s12916-014-0211-5 · Cited by 128
Testosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
Stanworth, R. D., & Jones, T. H. (2008) · Frontiers of hormone research · doi:10.1159/000176046 · Cited by 117
MALE HORMONE REPLACEMENT THERAPY INCLUDING “ANDROPAUSE”
Tenover, J. L. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70050-5 · Cited by 114
The Relationship between Testosterone Deficiency and Men's Health
Tsujimura, A. (2013) · The World Journal of Men s Health · doi:10.5534/wjmh.2013.31.2.126 · Cited by 115
Testosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Behre, H. M., Tammela, T. L. J., Arver, S., Tolrà, J. R., Bonifacio, V., Lamche, M., Kelly, J., Hiemeyer, F. J., for the European Testogel® Study Team, Giltay, E. J., et al. (2012) · The Aging Male · doi:10.3109/13685538.2012.699562 · Cited by 107
Tchernof, A., Labrie, F., Bélanger, A., Prud'homme, D., Bouchard, C., Tremblay, A., Nadeau, A., & Després, J.-P. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00125-1 · Cited by 107
Androgens and abdominal obesity
Mrin, P., & Arver, S. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80191-2 · Cited by 106
Self-citationThe triad of erectile dysfunction, hypogonadism and the metabolic syndrome
Shabsigh, R., Arver, S., Channer, K. S., Ian Eardley, C., Fabbri, A., Gooren, L. J., Heufelder, A. E., Jones, H., Meryn, S., & Zitzmann, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01696.x · Cited by 105
Betancourt-Albrecht, M., & Cunningham, G. R. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901031 · Cited by 102
The android woman – a risky condition
Björntorp, P. A. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.364690000.x · Cited by 101
Self-citationThe role of testosterone in the metabolic syndrome: A review
Saad, F., & Gooren, L. J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.022 · Cited by 100
Lönn, L., Kvist, H., Ernest, I., & Sjöström, L. (1994) · Metabolism · doi:10.1016/0026-0495(94)90010-8 · Cited by 100
Self-citationRosmond, R., Holm, G., & Björntorp, P. A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801173 · Cited by 97
Self-citationColman, E. G., Katzel, L. I., Rogus, E. M., Coon, P. J., Muller, D. C., & Goldberg, A. P. (1995) · Metabolism · doi:10.1016/0026-0495(95)90153-1 · Cited by 97
Traish, A. M. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000086 · Cited by 95
Kaufman, J., & Vermeulen, A. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_16 · Cited by 92
Testosterone therapy decreases subcutaneous fat and adiponectin in aging men
Frederiksen, L., Højlund, K., Hougaard, D. M., Mosbech, T. H., Larsen, R., Flyvbjerg, A., Frystyk, J., Brixen, K., & Andersen, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0565 · Cited by 93
Willemse, P.-P. M., Burggraaf, J., Hamdy, N. A. T., Weijl, N. I., VOSSEN, C. Y., van Wulften, L., Tol, A. Q. M. J. V. S.-V., Rosendaal, F. R., & Osanto, S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.226 · Cited by 93
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Jones, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 91
Basu, R., Man, C. D., Campioni, M., Basu, A., Nair, K. S., Jensen, M. D., Khosla, S., Klee, G., Toffolo, G., Cobelli, C., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0359 · Cited by 91
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 98
Risks Versus Benefits of Testosterone Therapy in Elderly Men
Basaria, S. S., & Dobs, A. S. (1999) · Drugs & Aging · doi:10.2165/00002512-199915020-00006 · Cited by 90
Swerdloff, R. S., & Wang, C. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.03.011 · Cited by 88
Metadata
- Authors
- Mårin, P., Holmtäng, S., Gustafsson, C., Jönsson, ‡., Kvist, ‡., Elander, A., Eldh, J., Sjöström, L., Holm, G., & Björntorp, P.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Mårin, Per
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 1993-07
- Volume
- 1
- Issue
- 4
- Pages
- 245-251
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2009810419
- Cited by
- 345
- References
- 19
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 14 · 2016: 8 · 2015: 17 · 2014: 18 · 2013: 18 · 2012: 19
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Obesity Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- androgen therapy, abdominal obesity, testosterone, dihydrotestosterone, visceral fat, glucose disposal, insulin sensitivity, gonadotropins, blood pressure, lipid profile, middle-aged men, prostate volume
- MeSH terms
- Adult, Aged, Androgens, Blood Glucose, Blood Pressure, Body Composition, Body Weight, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Double-Blind Method, Glucose, Gonadotropins, Humans, Male, Middle Aged, Obesity, Placebos, Risk Factors, Sex Hormone-Binding Globulin, Dihydrotestosterone, Testosterone, Time Factors, Tomography, X-Ray Computed, Triglycerides, Prostate-Specific Antigen, Abdominal Fat, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review